Literature DB >> 25835051

Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression.

Safak Korkmaz1, Onur Konuk2.   

Abstract

PURPOSE: To compare the long-term visual outcomes after 2-wall (medial-lateral) versus 3-wall (medial-lateral-inferior) orbital decompression combined with fat removal in patients with dysthyroid optic neuropathy (DON).
METHODS: Records of 68 eyes of 42 patients were retrospectively reviewed. Two-and 3-wall decompression was performed in 41 and 27 eyes, respectively. Transcaruncular approach was used for medial wall decompression. Lateral canthotomy combined with upper eyelid crease incision was used for lateral wall removal, and combined with transconjunctival lower eyelid incision if floor decompression performed. Outcome measures were visual acuity (VA), color vision, Hertel measures, visual field mean deviation (MD) and pattern standard deviation (PSD) Result: The mean follow-up time was 39.3 months (range, 12-72 months). All indicators of visual function significantly improved after 2-and 3-wall decompression. The improvement in VA and color vision was similar between groups. (logMAR VA: 2-wall: 0.52 ± 0.68 versus 3-wall: 0.71 ± 0.86, p = 0.335); (color vision on Ishihara plates: 2-wall: 10.1 ± 8.1 versus 3-wall: 11.6 ± 7.8, p = 0.447). The improvement in MD and PSD were higher after 3-wall decompression (MD: 2-wall: 10.0 ± 5.5 versus 3-wall: 14.3 ± 7.5 dB, p = 0.020); (PSD: 2-wall: 3.5 ± 1.9 versus 3-wall: 4.8 ± 3.0 dB, p = 0.045). Proptosis reduction was higher after 3-wall decompression (2-wall: 5.1 ± 1.3 versus 3-wall: 7.2 ± 1.9 mm, p = 0.0001). New onset diplopia was seen 20% and 28.5% of cases in 2-and 3-wall decompression, respectively. No adnexal/orbital complications were seen in 2-wall group, however orbital hematoma (1 case) and persisting eyelid edema (1 case) were encountered in 3-wall group.
CONCLUSION: Both 2-and 3-wall orbital decompressions are safe and effective for management of visual dysfunction in DON. Although 3-wall decompression provide better improvement in the parameters of visual field analysis and Hertel measures, new onset diplopia, adnexal/orbital complications are more common with this technique.

Entities:  

Keywords:  Dysthyroid optic neuropathy; mean deviation; pattern standard deviation; three-wall orbital decompression; two-wall orbital decompression

Mesh:

Year:  2015        PMID: 25835051     DOI: 10.3109/02713683.2015.1008641

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  12 in total

Review 1.  Therapeutic difference between orbital decompression and glucocorticoids administration as the first-line treatment for dysthyroid optic neuropathy: a systematic review.

Authors:  Ming-Na Xu; Zhao-Qi Pan; Yun-Hai Tu; He-Qing Tao; Ke-Si Shi; Wen-Can Wu
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

2.  [Orbital decompression : Indications, technique, results].

Authors:  H-J Welkoborsky; S K Graß; J Küstermeyer; K V Steinke
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

3.  Endoscopic orbital decompression for proptosis in non-thyroid eye disease.

Authors:  Valerie Juniat; J Anthony McGilligan; David Curragh; Dinesh Selva; Saul Rajak
Journal:  Oral Maxillofac Surg       Date:  2019-12-19

4.  Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.

Authors:  Sandra Rezar-Dreindl; Andrea Papp; Arnulf Baumann; Thomas Neumayer; Katharina Eibenberger; Eva Stifter; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-22       Impact factor: 3.535

5.  Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results.

Authors:  Mehmet Ozgur Cubuk; Onur Konuk; Mehmet Unal
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

Review 6.  Orbital decompression for thyroid eye disease: methods, outcomes, and complications.

Authors:  J M Jefferis; R K Jones; Z I Currie; J H Tan; S M Salvi
Journal:  Eye (Lond)       Date:  2017-12-15       Impact factor: 3.775

Review 7.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

8.  Effect of orbital decompression on dysthyroid optic neuropathy: A retrospective case series.

Authors:  Qiao-Wen Liang; Huasheng Yang; Wenjing Luo; Jian-Feng He; Yi Du
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 9.  Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient.

Authors:  Eman Al-Sharif; Adel H Alsuhaibani
Journal:  Saudi J Ophthalmol       Date:  2017-06-14

10.  The Therapeutic Effect of Combination of Orbital Decompression Surgery and Methylprednisolone Pulse Therapy on Patients with Bilateral Dysthyroid Optic Neuropathy.

Authors:  Jianan Xu; Huijing Ye; Guo Chen; Jingqiao Chen; Rongxin Chen; Huasheng Yang
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.